Updated: May 19, 2026

Leonard E Post

QUREuniQure N.V.SEC CIK: 0001235862
Estimated Net Worth
$2.5 Million
Last Updated: May 19, 2026 11:11 PM EST

Transaction Summary

Total Transactions39
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions21

Transaction Volume

Total Volume-$1.63M
Net Volume$1.63M
Buy Volume$0.00
Sell Volume-$1.63M

Trade Analysis

AVG Trade Size-$41.98K
Largest Trade$0.00
Most Active MonthJun
Most Active Year2025

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Leonard E Post has an estimated net worth of $2.5 Million. This is based on reported shares across multiple companies, which include uniQure N.V., Fulgent Genetics, Inc., PRAECIS PHARMACEUTICALS INC, ONYX PHARMACEUTICALS INC, and CG Oncology, Inc..



2025 was Leonard E Post's most active year for acquiring shares with 14 total transactions. Leonard E Post's most active month to acquire stocks was the month of May. 2004 was Leonard E Post's most active year for disposing of shares, totalling 40 transactions. Leonard E Post's most active month to dispose stocks was the month of February. 2004 saw Leonard E Post paying a total of $280,000.00 for 88,000 shares, this is the most they've acquired in one year. In 2025 Leonard E Post cashed out on 34,112 shares for a total of $579,778.40, their largest year based on trade value.

Holdings & Transactions

QUREuniqure n.v.
Updated: Jun 24, 2025VIEW QUOTE
Form TypeSEC Filing
-0.072.11K$14.45-$30.52K29.94KJun 20View
0.9823.60K47.68KJun 11View
1.5023.92K39.92KJun 19View
-0.122.22K$5.14-$11.42K16.00KJun 13View
1.9923.47K$18.83-$43.14K35.28KJun 13 - 16View
-0.03389.00$19.73-$7.67K11.81KFeb 27View
8.6226.89K30.01KJun 15View
-0.20795.00$16.64-$13.23K3.12KFeb 28View
1.754.18K6.56KFeb 24View
6.49K6.49KFeb 25View
10.00K10.00KSep 15View
View
CGONcg oncology, inc.
Updated: Nov 18, 2025VIEW QUOTE
Form TypeSEC Filing
-0.011.00K$21.02-$40.83K117.08KNov 17View
-0.011.00K$21.93-$42.65K118.08KOct 13View
-0.045.00K$20.35-$197.45K119.08KSep 30View
-0.011.00K$17.85-$34.50K124.08KSep 15View
-0.011.00K$14.30-$27.40K125.08KSep 03View
-0.022.00K$14.30-$54.80K126.08KJul 17View
24.16K24.17KJun 05View
-0.011.00K$14.30-$27.40K128.08KMay 21View
-0.011.00K$15.68-$30.16K129.08KApr 28View
-0.011.00K$14.30-$27.40K130.08KMar 17View
-0.011.00K$14.61-$28.01K131.08KFeb 18View
-0.011.00K$15.13-$29.06K132.08KJan 13View
-0.011.00K$14.72-$28.24K133.08KDec 16View
-0.011.00K$17.57-$33.94K134.08KDec 06View
15.60K15.60KOct 04View
View
FLGTfulgent genetics, inc.
Updated: Aug 03, 2022VIEW QUOTE
Form TypeSEC Filing
8.00K8.00KAug 01View
View
praecis pharmaceuticals inc
Updated: Feb 08, 2007
Form TypeSEC Filing
-1.004.00K$0.92-$3.68KFeb 07View
4.00K4.00KNov 10View
10.00K10.00KNov 11View
View
onyx pharmaceuticals inc
SVP, Research & Development Officer
Updated: Mar 11, 2005
Form TypeSEC Filing
60.00K60.00KMar 09View
-0.058.00K$33.14-$370.35K166.73KApr 26View
-0.0510.00K$24.76-$295.06K174.73KMar 26View
-0.0510.00K$23.01-$260.21K184.73KMar 22View
50.00K50.00KMar 02View